Zevra Therapeutics Statistics
Total Valuation
ZVRA has a market cap or net worth of $621.98 million. The enterprise value is $481.64 million.
Important Dates
The next confirmed earnings date is Wednesday, November 5, 2025, after market close.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ZVRA has 56.14 million shares outstanding. The number of shares has increased by 33.78% in one year.
| Current Share Class | 56.14M |
| Shares Outstanding | 56.14M |
| Shares Change (YoY) | +33.78% |
| Shares Change (QoQ) | +4.12% |
| Owned by Insiders (%) | 0.86% |
| Owned by Institutions (%) | 49.54% |
| Float | 46.86M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 94.30 |
| PS Ratio | 9.39 |
| Forward PS | 4.79 |
| PB Ratio | 5.21 |
| P/TBV Ratio | 5.90 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.77 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.85, with a Debt / Equity ratio of 0.53.
| Current Ratio | 7.85 |
| Quick Ratio | 7.66 |
| Debt / Equity | 0.53 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -7.12 |
Financial Efficiency
Return on equity (ROE) is 3.53% and return on invested capital (ROIC) is -27.82%.
| Return on Equity (ROE) | 3.53% |
| Return on Assets (ROA) | -18.85% |
| Return on Invested Capital (ROIC) | -27.82% |
| Return on Capital Employed (ROCE) | -26.56% |
| Revenue Per Employee | $1.05M |
| Profits Per Employee | -$66,237 |
| Employee Count | 59 |
| Asset Turnover | 0.31 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ZVRA has paid $18.75 million in taxes.
| Income Tax | 18.75M |
| Effective Tax Rate | 87.64% |
Stock Price Statistics
The stock price has increased by +43.03% in the last 52 weeks. The beta is 1.49, so ZVRA's price volatility has been higher than the market average.
| Beta (5Y) | 1.49 |
| 52-Week Price Change | +43.03% |
| 50-Day Moving Average | 9.44 |
| 200-Day Moving Average | 8.91 |
| Relative Strength Index (RSI) | 58.93 |
| Average Volume (20 Days) | 1,860,706 |
Short Selling Information
The latest short interest is 7.99 million, so 14.24% of the outstanding shares have been sold short.
| Short Interest | 7.99M |
| Short Previous Month | 9.07M |
| Short % of Shares Out | 14.24% |
| Short % of Float | 17.06% |
| Short Ratio (days to cover) | 2.96 |
Income Statement
In the last 12 months, ZVRA had revenue of $62.02 million and -$3.91 million in losses. Loss per share was -$0.08.
| Revenue | 62.02M |
| Gross Profit | 44.63M |
| Operating Income | -60.41M |
| Pretax Income | 21.40M |
| Net Income | -3.91M |
| EBITDA | -53.85M |
| EBIT | -60.41M |
| Loss Per Share | -$0.08 |
Full Income StatementBalance Sheet
The company has $202.61 million in cash and $62.28 million in debt, giving a net cash position of $140.34 million or $2.50 per share.
| Cash & Cash Equivalents | 202.61M |
| Total Debt | 62.28M |
| Net Cash | 140.34M |
| Net Cash Per Share | $2.50 |
| Equity (Book Value) | 117.23M |
| Book Value Per Share | 2.13 |
| Working Capital | 197.51M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$46.21 million and capital expenditures -$312,000, giving a free cash flow of -$46.53 million.
| Operating Cash Flow | -46.21M |
| Capital Expenditures | -312,000 |
| Free Cash Flow | -46.53M |
| FCF Per Share | -$0.83 |
Full Cash Flow StatementMargins
Gross margin is 71.96%, with operating and profit margins of -97.41% and 4.26%.
| Gross Margin | 71.96% |
| Operating Margin | -97.41% |
| Pretax Margin | 34.50% |
| Profit Margin | 4.26% |
| EBITDA Margin | -86.82% |
| EBIT Margin | -97.41% |
| FCF Margin | n/a |
Dividends & Yields
ZVRA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -33.78% |
| Shareholder Yield | -33.78% |
| Earnings Yield | -0.63% |
| FCF Yield | -7.48% |
Analyst Forecast
The average price target for ZVRA is $22.57, which is 103.70% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $22.57 |
| Price Target Difference | 103.70% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 76.37% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 28, 2020. It was a reverse split with a ratio of 1:16.
| Last Split Date | Dec 28, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:16 |
Scores
ZVRA has an Altman Z-Score of -0.2 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.2 |
| Piotroski F-Score | 2 |
